Shandong Xinhua Pharmaceutical Company Limited (SHE:000756)

Market Cap	9.07B +8.3%
Revenue (ttm)	8.49B +1.9%
Net Income	382.16M -14.8%
EPS	0.55 -15.5%
Shares Out	n/a
PE Ratio	23.72
Forward PE	15.42
Dividend	0.25 (1.60%)
Ex-Dividend Date	Jul 18, 2025

Volume	6,242,953
Average Volume	14,344,215
Open	15.79
Previous Close	15.76
Day's Range	15.65 - 15.84
52-Week Range	12.51 - 18.70
Beta	-0.10
RSI	41.45
Earnings Date	Mar 30, 2026

About SHE:000756

Shandong Xinhua Pharmaceutical Company Limited develops, manufactures, and sells bulk pharmaceuticals, preparations, and chemical products in the People’s Republic of China, the Americas, Europe, and internationally. The company offers antipyretic and analgesic, cardiovascular and cerebrovascular, anti-infective, and central nervous drugs under the Xinhua brand; and contract manufacturing services for active pharmaceutical ingredients and pharmaceutical intermediates, OTC, and generics. It also provides ibuprofen bulk pharmaceutical products; a...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1943
• Employees: 7,159
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000756

Financial Performance

In 2024, SHE:000756's revenue was 8.47 billion, an increase of 4.51% compared to the previous year's 8.10 billion. Earnings were 470.02 million, a decrease of -5.33%.